
Sign up to save your podcasts
Or
Jonathan Long is a biochemist who studies the chemicals produced during exercise. In Long’s world, “you always start with molecules,” which offer “clean handles” to understanding complex processes. His lab has identified a chemical produced in the digestive tract during exercise that can make a person stop eating. Long now studies this “gut-brain axis” for ways to treat obesity, diabetes, and, perhaps, even age-related conditions like dementia, as he tells host Russ Altman on this episode of Stanford Engineering’s The Future of Everything podcast.
Episode Reference Links:
Connect With Us:
Chapters:
(00:00:00) Introduction
Host Russ Altman introduces guest Jonathan Long, a professor of pathology at Stanford University
(00:02:30) Effective Weight Loss Drugs
The increase of effective weight loss drugs, and the history and development of these GLP-1 receptor agonists.
(00:04:03) Understanding Metabolism and Exercise
Outline of metabolic chemicals released during physical activity and their potential to combat obesity and diabetes.
(00:05:38) Animal Models in Exercise Studies
The use of animal models in exercise studies and the discovery of Lac-Phe.
(00:07:15) Psychological Preparation for Exercise
The psychological aspects of exercise and the involvement of endocannabinoids in exercise motivation.
(00:09:28) Lac-Phe's Role and Mechanism
The role of Lac-Phe and its production in the gut.
(00:12:21) Differences in Exercise Response
Differences in exercise response between trained athletes and untrained individuals.
(00:13:25) Diabetes and Metabolic Diseases
The relationship between diabetes, exercise, and metabolic diseases.
(00:15:29) Lac-Phe as a Potential Therapeutic
The potential of Lac-Phe as a weight loss drug, and parallels to GLP-1 drug development.
(00:16:48) Importance of How Weight is Lost
Whether the method of weight-loss matters, and the importance of preserving lean muscle mass.
(00:19:40) Exercise as Medicine
The concept of exercise as medicine, and defining physical activity at the same resolution as modern medicines.
(00:22:39) Metformin and Exercise Pathways
The unexpected connection between metformin and the Lac-Phe pathway.
(00:24:08) Prospects of an Exercise Pill
The future of an exercise pill, and the scientific challenges associated with its development.
(00:27:33) Conclusion
Connect With Us:
Episode Transcripts >>> The Future of Everything Website
Connect with Russ >>> Threads / Bluesky / Mastodon
Connect with School of Engineering >>>Twitter/X / Instagram / LinkedIn / Facebook
4.8
127127 ratings
Jonathan Long is a biochemist who studies the chemicals produced during exercise. In Long’s world, “you always start with molecules,” which offer “clean handles” to understanding complex processes. His lab has identified a chemical produced in the digestive tract during exercise that can make a person stop eating. Long now studies this “gut-brain axis” for ways to treat obesity, diabetes, and, perhaps, even age-related conditions like dementia, as he tells host Russ Altman on this episode of Stanford Engineering’s The Future of Everything podcast.
Episode Reference Links:
Connect With Us:
Chapters:
(00:00:00) Introduction
Host Russ Altman introduces guest Jonathan Long, a professor of pathology at Stanford University
(00:02:30) Effective Weight Loss Drugs
The increase of effective weight loss drugs, and the history and development of these GLP-1 receptor agonists.
(00:04:03) Understanding Metabolism and Exercise
Outline of metabolic chemicals released during physical activity and their potential to combat obesity and diabetes.
(00:05:38) Animal Models in Exercise Studies
The use of animal models in exercise studies and the discovery of Lac-Phe.
(00:07:15) Psychological Preparation for Exercise
The psychological aspects of exercise and the involvement of endocannabinoids in exercise motivation.
(00:09:28) Lac-Phe's Role and Mechanism
The role of Lac-Phe and its production in the gut.
(00:12:21) Differences in Exercise Response
Differences in exercise response between trained athletes and untrained individuals.
(00:13:25) Diabetes and Metabolic Diseases
The relationship between diabetes, exercise, and metabolic diseases.
(00:15:29) Lac-Phe as a Potential Therapeutic
The potential of Lac-Phe as a weight loss drug, and parallels to GLP-1 drug development.
(00:16:48) Importance of How Weight is Lost
Whether the method of weight-loss matters, and the importance of preserving lean muscle mass.
(00:19:40) Exercise as Medicine
The concept of exercise as medicine, and defining physical activity at the same resolution as modern medicines.
(00:22:39) Metformin and Exercise Pathways
The unexpected connection between metformin and the Lac-Phe pathway.
(00:24:08) Prospects of an Exercise Pill
The future of an exercise pill, and the scientific challenges associated with its development.
(00:27:33) Conclusion
Connect With Us:
Episode Transcripts >>> The Future of Everything Website
Connect with Russ >>> Threads / Bluesky / Mastodon
Connect with School of Engineering >>>Twitter/X / Instagram / LinkedIn / Facebook
4,336 Listeners
246 Listeners
1,268 Listeners
32,073 Listeners
1,003 Listeners
324 Listeners
3,964 Listeners
1,436 Listeners
38 Listeners
260 Listeners
141 Listeners
99 Listeners
261 Listeners
95 Listeners
420 Listeners
42 Listeners